Pharmaceutical Technology

JULY 14, 2022

Historically, the pharmaceutical industry has failed to meet the needs of this patient population. Centralised incentives are also in place across Europe, as well as at the national level in some EU states. Go-to-market strategies. The choice of where to launch an orphan drug is an important and difficult decision.

Drugs 147

Drugs Medicine Marketing Development 147

pharmaphorum

JANUARY 21, 2022

The Oslo Medicines Initiative (OMI), which held its first public webinar event last week, was conceived before the pandemic, but it has gained new relevance as it seeks to address this disparity in Europe, a union of countries with hugely varying income levels. WHO is OMI? The current situation, said Muscat, is “unacceptable”.

Medicine 52

Medicine Marketing Manufacturing Production 52

Pharmaceutical Technology

JANUARY 27, 2023

cases per million in Europe. In an email to Pharmaceutical Technology , he further described the therapy as “the most important advance for treatment of TTP since the documentation of effectiveness of plasma exchange in 1991”. GlobalData is the parent company of Pharmaceutical Technology. However, obstacles still remain.

Manufacturing 130

Manufacturing Drugs Research Analyst FDA Approval 130

Drug Discovery World

NOVEMBER 13, 2023

Ahead of protein and antibody engineering conference PEGS Europe 2024 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting. He will discuss selection technologies for membrane targets using advances in whole cell panning and comparative deep sequencing.

Protein 59

Protein Antibody Engineer Scientist 59

Drug Discovery World

NOVEMBER 9, 2023

Ahead of protein and antibody engineering conference PEGS Europe 2024 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting. Iain Moal, PhD, Scientific Leader, Computational Antibody Engineering, GSK, on: ‘Learning antibody binding affinity using FACS and NGS’.

Engineer 52

Engineer Antibody Protein In-Vivo 52

The Pharma Data

MAY 4, 2021

and developed Europe following the approvals in 2019 for combinations of certain immune checkpoint inhibitors and Inlyta for the first-line treatment of patients with advanced renal cell carcinoma; as well as. In April 2021, Pfizer announced that it has acquired Amplyx Pharmaceuticals, Inc. in December 2019; and.

Vaccination 40

Vaccination Vaccine Production Sales 40